These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 8438454)

  • 21. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 22. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
    Morris RE; Wu J; Shorthouse R
    Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
    [No Abstract]   [Full Text] [Related]  

  • 25. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Smith S; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 27. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
    Belitsky P; Gulanikar A; He G; Gupta R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
    [No Abstract]   [Full Text] [Related]  

  • 29. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression.
    D'Silva M; DeRoover A; Nishimura Y; Antoniou E; Candinas D; Hubscher SG; McMaster P
    Transplant Proc; 1996 Apr; 28(2):948-9. PubMed ID: 8623475
    [No Abstract]   [Full Text] [Related]  

  • 31. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 32. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
    Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
    Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Morris RE; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse R; Berry GJ
    Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888
    [No Abstract]   [Full Text] [Related]  

  • 35. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats.
    Wang ME; Stepkowski SM; Ferraresso M; Kahan BD
    Transplantation; 1992 Oct; 54(4):704-9. PubMed ID: 1412762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Baohuoside-1 aglycone and tacrolimus monotherapy and combination therapy on prevention of acute heart allograft rejection in the rat.
    Qi S; Zhao H; Ma A; Liu L; Wang X; Xu D; Lin G; Tamura K; Jiang H; Daloze P; Chen H
    Microsurgery; 2007; 27(4):268-70. PubMed ID: 17477431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.